Whitepaper: CMC for Fab and Fc-fusion development programmes
Posted in News
|A new whitepaper is now available from Lonza Biologics entitled ‘A comprehensive and flexible approach to CMC for Fab and Fc-fusion development programs’.
- Gain insights into the diverse and complex structures of new molecular formats, often encompassing multiple chains and multiple domains
- Understand the unique challenges faced during the process development and manufacture of these advanced proteins
- Explore how characterising these products and developing robust manufacturing processes can help to usher them to market and provide new treatment options for diseases which are currently challenging to treat
